Factors predicting reoperation of chronic subdural hematoma following primary surgical evacuation

Journal of Neurosurgery
|December 16, 2017
PubMed

Insights

Predicting reoperation for chronic subdural hematoma (CSDH) is crucial. Key factors include medication use (clopidogrel or warfarin), hematoma loculation, and the degree of hematoma reduction after surgery. Complete resolution significantly lowers reoperation rates.

Area of Science:

  • Neurosurgery
  • Radiology
  • Medical Informatics

Background:

  • Chronic subdural hematoma (CSH) is a common neurosurgical condition.
  • High reoperation rates following surgical evacuation of CSH remain a significant clinical challenge.
  • Identifying predictors of reoperation is essential for optimizing patient outcomes.

Purpose of the Study:

  • To evaluate the prognostic value of clinical and radiographic factors in predicting the need for reoperation in patients with CSH.
  • To identify key indicators that can help neurosurgeons anticipate and potentially mitigate CSH reoperation.

Main Methods:

  • A retrospective review of 325 CSH patients treated at a US academic medical center from 2006 to 2016.
  • Analysis of clinical data and radiographic imaging (MRI and CT) to identify factors associated with reoperation.
  • Univariable and multivariable statistical analyses were performed to determine significant predictors.

Main Results:

  • Warfarin or clopidogrel use, T1-weighted MRI mixed intensity, preoperative midline shift, postoperative fluid residual, and lack of intraoperative irrigation were associated with higher reoperation rates in univariable analysis.
  • Multivariable analysis identified hematoma loculation, anticoagulant use (clopidogrel/warfarin), and the percentage of hematoma thickness change post-surgery as significant predictors of reoperation.
  • A hematoma thickness change of 0%, 50%, and 100% correlated with reoperation rates of 41%, 6%, and <1%, respectively. Drain use did not impact reoperation likelihood.

Conclusions:

  • Hematoma loculation, use of clopidogrel or warfarin, and the extent of hematoma evacuation on postoperative CT are the strongest predictors of reoperation for CSH.
  • The degree of hematoma size reduction after initial surgery is a critical factor in determining the need for subsequent reoperation.
  • These findings can aid in risk stratification and surgical decision-making for CSH management.

Related Concept Videos